Epoprostenol (FLOLAN) is an intravenous medication used to treat primary pulmonary hypertension (PPH), a condition characterized by progressive increases in pulmonary artery pressure, leading to right ...
Dallas, TX - As new agents are developed for the treatment of primary pulmonary hypertension (PPH), long-term data are now becoming available on the first drug approved for this indication, ...
Myogen Receives Flolan Rights in U.S. and Will Launch Commercial Operations in Q2 '06 GlaxoSmithKline (LSE: GSK) (NYSE: GSK) and Myogen, Inc. (Nasdaq: MYOG) today announced a two-part collaboration in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results